Researchers argue that, in some situations where machine-learning models are used to allocate scarce resources or opportunities, randomizing decisions in a structured way may lead to fairer outcomes.
Using MR-SPI and AlphaFold3, scientists unravel the molecular underpinnings of Alzheimer’s disease, identifying key protein changes that could reshape future treatments. Study: Deciphering proteins in ...
New research reveals a statistical technique used in Alzheimer's drug trials inflates clinical efficacy claims by 29x.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results